3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Multiple Myeloma
3
Leukemia, Myeloid, Acute
3
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Myelodysplastic Syndromes
2
Lymphoma, Non-Hodgkin
2
Lymphoma
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Burkitt Lymphoma
2
Waldenstrom Macroglobulinemia
1
Thrombocythemia, Essential
1
Sezary Syndrome
1
Rhabdomyosarcoma, Embryonal
1
Rhabdomyosarcoma, Alveolar
1
Rhabdomyosarcoma
1
Recurrence
1
Pseudomyxoma Peritonei
1
Primary Myelofibrosis
1
Precancerous Conditions
1
Polycythemia Vera
1
Pdgfra-Associated Chronic Eosinophilic Leukemia
1
Neurofibrosarcoma
1
Neurofibromatosis 1
1
Neoplasms, Plasma Cell
1
Neoplasms
1
Myeloproliferative Disorders
1
Myelodysplastic-Myeloproliferative Diseases
1
Mycosis Fungoides
1
Multi-centric Castleman's Disease
1
Macular dystrophy, corneal type 1
1
Interventions
Bevacizumab
11
atezolizumab
8
Specimen Handling
7
Magnetic Resonance Spectroscopy
7
Nivolumab
6
durvalumab
4
lenvatinib
3
cabozantinib
3
Ipilimumab
3
ulixertinib
2
tremelimumab
2
tislelizumab
2
relatlimab
2
donafenib
2
camrelizumab
2
apatinib
2
X-Rays
2
Surgical Procedures, Operative
2
Sorafenib
2
Oxaliplatin
2
Leucovorin
2
Immunotherapy
2
Fluorouracil
2
Fluorodeoxyglucose F18
2
trifluridine tipiracil drug combination
1
trastuzumab biosimilar HLX02
1
trametinib
1
sonidegib
1
sofosbuvir-velpatasvir drug combination
1
sintilimab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Hepatocellular
×
Sirolimus
×
30 days
×
Clear all
No trials found.